ERRα is a marker of tamoxifen response and survival in triple-negative breast cancer

PURPOSE: Estrogen-related receptor alpha (ERRα) signaling has recently been implicated in breast cancer. We investigated the clinical value of ERRα in randomized cohorts of tamoxifen-treated and adjuvant-untreated patients. EXPERIMENTAL DESIGN: Cox proportional hazards regression was used to evaluat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Manna, Subrata, Bostner, Josefine, Sun, Yang, Miller, Lance D., Alayev, Anya, Schwartz, Naomi S., Lager, Elin, Fornander, Tommy, Nordenskjöld, Bo, Yu, Jane J., Stål, Olle, Holz, Marina K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4794381/
https://ncbi.nlm.nih.gov/pubmed/26542058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0857
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados